• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OSCOR INC. TOURGUIDE STEERABLE SHEATH; INTRODUCER, CATHETER, PRODUCT CODE: DYB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OSCOR INC. TOURGUIDE STEERABLE SHEATH; INTRODUCER, CATHETER, PRODUCT CODE: DYB Back to Search Results
Model Number TG0705509
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/19/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Conclusion not yet available, evaluation in process.A follow-up will be submitted as soon as the investigation is complete.
 
Event or Problem Description
It was reported that the orange anti-return valve introducer does not work; resulting in blood reflux.The person or patient involved is showing an increase in blood loss.Procedure completed with another device.No additional information available at this time.
 
Additional Manufacturer Narrative
Changed aptus endosystems steerable sheath to tourguide steerable sheath.The device was used in treatment.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections.The device was not returned for analysis, therefore, the exact cause of the product issue cannot be determined and the clinical observation could not be confirmed.However, following controls are in place to mitigate the reported product issue.Per qa procedure (destino steerable guiding sheath in-process and final inspection) leak test: perform leak test according to procedures based on available leak tester.The leak test is performed by manufacturing personnel and is observed by quality assurance personnel.This procedure is performed 100%.Per ifu: use the sideport, located at the handle, to inject contrast solution or flush the steerable sheath.The steerable sheath must be thoroughly flushed with either saline or heparinized saline and free of air prior to use to avoid air embolism to the patient.Wet the dilator shaft with sterile saline solution prior to insertion through the hemostatic valve.Note: any device/component inserted through the hemostatic valve of the sheath should be wet and placed through the center of the valve to prevent tearing of the seal and leakage.No further follow-up action required.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
 
Additional Manufacturer Narrative
The following sections were updated in follow-up 2.B3, b4, g3, g6, h2, h10, h11.Correction b3: corrected event date from 03/09/2021 to 03/19/2021.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOURGUIDE STEERABLE SHEATH
Common Device Name
INTRODUCER, CATHETER, PRODUCT CODE: DYB
Manufacturer (Section D)
OSCOR INC.
3816 desoto blvd.
palm harbor FL 34683 1816
MDR Report Key11947263
Report Number1035166-2021-00056
Device Sequence Number1085348
Product Code DYB
UDI-Device Identifier00850232006079
UDI-Public00850232006079
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
K120459
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source distributor,foreign
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/01/2023
Device Model NumberTG0705509
Device Catalogue NumberTG0705509
Device Lot NumberC8-20783
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/11/2021
Supplement Date Received by Manufacturer08/11/2021
09/30/2021
Initial Report FDA Received Date06/07/2021
Supplement Report FDA Received Date09/01/2021
09/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-